Pharmidex Pharmaceutical Services Limited

Phone: +44 870 240 5978

E-mail: bd@pharmidex.com

Web: https://www.pharmidex.com

Pharmidex Pharmaceutical Services Limited is a UK-based Contract Research Organisation (CRO), founded in 2002, providing GLP- and GCP-compliant preclinical and clinical support services to biotechnology and pharmaceutical companies worldwide. With over two decades of experience, Pharmidex partners with sponsors to generate high-quality, regulatory-ready data that supports confident decision-making from discovery through to clinical development.

Regulatory & Quality Framework

Pharmidex operates to the highest standards of scientific and regulatory compliance, offering:

• GLP-compliant bioanalysis, toxicokinetics (TK), pharmacokinetics (PK), and preclinical support
• GCP-compliant bioanalytical services for clinical studies
• AAALAC-accredited in vivo facilities
• Robust QA oversight ensuring data integrity, traceability, and inspection readiness

Our quality systems are designed to meet the expectations of global regulators and to support IND/CTA-enabling and clinical programs.

Core Capabilities

Pharmidex provides an integrated portfolio of services, including:

• Regulatory Bioanalysis (GLP & GCP):
  PK, TK, biomarker and immunogenicity analysis using validated LC-MS/MS and ligand-binding assay platforms
• DMPK & ADME:
  In vitro and in vivo metabolism, PK and exposure assessments to inform lead optimisation and development strategy
• Preclinical In Vivo & In Vitro Services:
  Bespoke pharmacology, molecular biology, pathology and translational models across multiple therapeutic areas
• Discovery & Translational Support:
  Flexible, science-led solutions bridging early discovery through to regulated development
• Specialist Testing Platforms:
  Support for complex modalities, combination products and advanced biological systems

Why Pharmidex

• GLP and GCP expertise under one organisation, enabling seamless transition from preclinical to clinical support
• Experienced scientific leadership with deep industry knowledge across CNS, respiratory, oncology, immunology and ADME
• Flexible, client-focused delivery, tailored to biotech and pharma timelines
• Single-site efficiency, improving communication, speed and data quality

Our Commitment

Pharmidex is committed to delivering scientifically rigorous, regulator-ready data through a collaborative and transparent approach. We work closely with our partners to de-risk development programmes and accelerate the progression of innovative therapies toward patients.

For detailed contact information visit location pages below.